Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease

Abstract Introduction: In December 2016, an outbreak of sylvatic yellow fever (YF) occurred in the non-endemic areas of the south-eastern region of Brazil. The immune response to the yellow fever vaccine and its safety in individuals with chronic kidney disease (CKD) living in YF-endemic regions ar...

Full description

Bibliographic Details
Main Authors: Jesiree Iglésias Quadros Distenhreft, Dinair Couto-Lima, Cecilia Siliansky de Andreazzi, Juliana Feu Rosa Carrera Thomazini, Lauro Monteiro Vasconcellos Filho, Aloísio Falqueto, Weverton Machado Luchi
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2024-08-01
Series:Brazilian Journal of Nephrology
Subjects:
Renal Insufficiency
Chronic
Efficacy
Antibodies
Neutralizing
Safety
Yellow Fever Vaccine
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024000400306&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024000400306&lng=en&tlng=en

Similar Items